-
公开(公告)号：KR1020130009416A
公开(公告)日：2013-01-23
申请号：KR1020110070521
申请日：2011-07-15
Applicant: 성균관대학교산학협력단
IPC: A61K31/428 , A61K31/425 , A61K9/16 , A61K9/22
CPC classification number: A61K31/428 , A61K9/16 , A61K9/20 , A61K47/38
Abstract: PURPOSE: A sustained release microparticle containing pramipexole and ethyl cellulose and an orally fast disintegrating tablet containing the same are provided to maintain effective blood concentration and to improve drug compliance. CONSTITUTION: A sustained release microparticle of pramipexole contains 1 part by weight of pramipexole or a salt thereof and 13-33 parts by weight of ethyl cellulose. The salt is pramipexole hydrochloride. The viscosity of ethyl cellulose is 6-22 cp. An orally fast disintegrating tablet contains the sustained release granules, sugar alcohol, and a disintegrant. The orally fast disintegrating tablet contains 50-55 parts by weight of sugar alcohol based on 100 parts by weight of the sustained release granules. The orally fast disintegrating tablet additionally contains an excipient. [Reference numerals] (AA) Elution rate; (BB) Time(hour); (CC) Embodiment 3-1; (DD) Embodiment 3-2; (EE) Embodiment 3-3; (FF) Embodiment 3-4
Abstract translation: 目的：提供含有普拉克索和乙基纤维素的持续释放微粒和含有它的口服快速崩解片，以保持有效的血液浓度并改善药物依从性。 构成：普拉克索的缓释微粒含有1重量份的普拉克索或其盐和13-33重量份的乙基纤维素。 盐是普拉克索盐酸盐。 乙基纤维素的粘度为6-22厘泊。 口服快速崩解片含有缓释颗粒，糖醇和崩解剂。 口服快速崩解片剂基于100重量份的缓释颗粒含有50-55重量份的糖醇。 口服快速崩解片还含有赋形剂。 （附图标记）（AA）洗脱率; （BB）时间（小时）; （CC）实施例3-1; （DD）实施例3-2; （EE）实施例3-3; （FF）实施例3-4
-
公开(公告)号：KR1020170107766A
公开(公告)日：2017-09-26
申请号：KR1020160031485
申请日：2016-03-16
Applicant: 주식회사 엘지화학 , 성균관대학교산학협력단
IPC: H01L51/42 , H01L31/0256
CPC classification number: H01L31/0256 , H01L51/42 , Y02E10/549
Abstract: 본발명은태양전지및 이의제조방법에관한것이다. 상기제조방법에따르면, 유기할로겐화물과금속할로겐화물을특정몰비로사용하여자발적으로재결합방지층이형성되도록유도하여고효율의페로브스카이트태양전지를제조할수 있다.
Abstract translation: 太阳能电池及其制造方法本发明涉 根据上述制造方法，通过诱导有机卤化物和金属卤化物以特定摩尔比自发形成复合防止层，可以制造高效的钙钛矿型太阳能电池。
-
公开(公告)号：KR1020140075662A
公开(公告)日：2014-06-19
申请号：KR1020140063999
申请日：2014-05-27
Applicant: 성균관대학교산학협력단
CPC classification number: A61K47/34 , A61K31/635
Abstract: The present invention relates to a eutectic composition comprising celecoxib and poloxamer. The eutectic composition comprising celecoxib and poloxamer according to one embodiment of the present invention includes celecoxib or pharmaceutically acceptable salt and block copolymer of poly (polyoxyethylene) and poly (Polyoxypropylene) and is manufactured by thermal melting.
Abstract translation: 本发明涉及包含塞来昔布和泊洛沙姆的共晶组合物。 根据本发明一个实施方案的包含塞来昔布和泊洛沙姆的共晶组合物包括塞来昔布或其可药用盐和聚（聚氧乙烯）和聚（聚氧丙烯）的嵌段共聚物，并且通过热熔制造。
-
公开(公告)号：KR1020130124113A
公开(公告)日：2013-11-13
申请号：KR1020120047766
申请日：2012-05-04
Applicant: 성균관대학교산학협력단
IPC: A61K9/08 , A61K47/48 , A61K31/44 , A61K31/404
CPC classification number: A61K47/10 , A61K31/635 , A61K47/40 , A61K9/08 , A61K31/404 , A61K31/44 , A61K47/50
Abstract: The present invention relates to an eutectic mixture having celecoxib with remarkably enhanced solubility and bioavailability through an eutetic reaction by adding poloxamer of chemical formula 2 to celecoxib of chemical formula 1 which is an insoluble drug. The weight ratio of poloxamer with respect to celecoxib is 3:7-6:4. More preferably, the eutectic mixture according to the present invention contains 1.5 parts by weight of poloxamer with respect to 1 part by weight of celecoxib. [Reference numerals] (AA) Temperature ;(BB) % celecoxib
Abstract translation: 本发明涉及一种具有塞来昔布的共晶混合物，其通过将化学式2的泊洛沙姆加入作为不溶性药物的化学式1的塞来昔布，通过可口反应显着提高溶解性和生物利用度。 泊洛沙姆相对于塞来昔布的重量比为3：7-6：4。 更优选地，根据本发明的共晶混合物相对于1重量份的塞来昔布含有1.5重量份泊洛沙姆。 （参考号）（AA）温度;（BB）％塞来昔布
-
公开(公告)号：KR1020130117415A
公开(公告)日：2013-10-28
申请号：KR1020120039750
申请日：2012-04-17
Applicant: 삼성전자주식회사 , 성균관대학교산학협력단
CPC classification number: H03F3/245 , H03F1/565 , H03F3/211 , H03F3/602 , H03F2200/192 , H03F2200/198 , H03F2200/204 , H03F2203/21139
Abstract: PURPOSE: An apparatus and a method for balanced power amplification are provided to offer a 90-degree hybrid splitter and a 90-degree hybrid combiner using at least one quarter-wave transmission line, thereby improving the efficiency of wireless power transmission. CONSTITUTION: An amplifier (600) comprises a 90-degree hybrid splitter (620), a first power amplifier (PA) (630), a second PA (640), and a 90-degree hybrid combiner (650). The 90-degree hybrid splitter divides an input signal into a first PA input signal and a second PA input signal which have 90-degree phase difference. The first PA amplifies the first PA input signal to generate a first PA output signal. The second PA amplifies the second PA input signal to generate a second PA output signal. The 90-degree hybrid combiner combines the first and second output signals having 90-degree phase difference of to generate an output signal. [Reference numerals] (AA) First PA input signal; (BB) First PA output signal; (CC) Output signal; (DD) Input signal; (EE) Second PA input signal; (FF) Second PA output signal
Abstract translation: 目的：提供一种用于平衡功率放大的装置和方法，以提供使用至少四分之一波长的传输线的90度混合分路器和90度混合组合器，从而提高无线功率传输的效率。 构成：放大器（600）包括90度混合分路器（620），第一功率放大器（PA）（630），第二PA（640）和90度混合组合器（650）。 90度混合分路器将输入信号分为具有90度相位差的第一PA输入信号和第二PA输入信号。 第一PA放大第一PA输入信号以产生第一PA输出信号。 第二PA放大第二PA输入信号以产生第二PA输出信号。 90度混合组合器组合具有90度相位差的第一和第二输出信号以产生输出信号。 （附图标记）（AA）第一PA输入信号; （BB）第一PA输出信号; （CC）输出信号; （DD）输入信号; （EE）第二PA输入信号; （FF）第二PA输出信号
-
Patent Agency Ranking
公开(公告)号：KR1020130037802A
公开(公告)日：2013-04-17
申请号：KR1020110102243
申请日：2011-10-07
Applicant: 성균관대학교산학협력단
IPC: A61K9/28 , A61K31/428 , A61K47/38
CPC classification number: A61K9/28 , A61K9/2866 , A61K31/428 , A61K47/38
Abstract: PURPOSE: A sustained release fine particle containing pramipexole and a composition containing the same are provided to ensure a release-controlling effect by additional coating of ethyl cellulose. CONSTITUTION: A composition is a release-controlled formulation which is prepared by coating a sustained release fine particle containing pramipexole or a salt thereof with a coating solution containing ethyl cellulose. The sustained release fine particle contains pramipezole or a salt thereof and hydroxypropyl methylcellulose. [Reference numerals] (AA) Elution rate(%); (BB) Time(h); (CC) Bead weight ratio of before coating : after coating = 1 : 1.5; (DD) Bead weight ratio of before coating : after coating = 1 : 1.3;
Abstract translation: 目的：提供含有普拉克索的缓释微粒和含有它们的组合物，以通过额外涂布乙基纤维素来确保释放控制效果。 构成：组合物是通过用含有乙基纤维素的涂布溶液涂布含有普拉克索或其盐的缓释微粒制备的释放控制制剂。 持续释放的微粒含有丙胺嘧啶或其盐和羟丙基甲基纤维素。 （AA）洗脱率（％） （BB）时间（h）; （CC）涂布前的珠重比：涂布后= 1：1.5; （DD）涂布前的珠重比：涂布后= 1：1.3;
-
17.发明公开히드록시프로필메틸셀룰로오스를 이용한 레보카바스틴 함유 나노현탁액의 제조방법 및 이로부터 제조된 레보카바스틴 함유 나노현탁액 无效通过使用羟丙基甲基纤维素制备含有左氧氟沙星的纳米颗粒的方法和制备含有左旋巴比妥的纳米抗体
公开(公告)号：KR1020130037770A
公开(公告)日：2013-04-17
申请号：KR1020110102182
申请日：2011-10-07
Applicant: 성균관대학교산학협력단
IPC: A61K9/10 , A61K47/38 , A61K31/445 , A61K9/00
CPC classification number: A61K9/10 , A61K9/0048 , A61K31/445 , A61K47/38
Abstract: PURPOSE: A method for preparing levocabastine-containing nanosuspension using hydroxypropyl methylcellulose is provided to enhance drug solubility by redispersion of a solid dispersant in an aqueous phase. CONSTITUTION: A method for preparing levocabastine-containing nanosuspension using hydroypropyl methylceullose comprises: a step of dissolving levocabastine and hydroxypropyl methylcellulose in a solvent and preparing a solid dispersant; and a step of dispersing the solid dispersant. The levocabastine is levocabastine hydrochloride. [Reference numerals] (AA) Particle size(nm); (BB) Example 1; (CC) Example 2; (DD) Example 3; (EE) Comparative example 1; (FF) Comparative example 2; (GG) Comparative example 3;
Abstract translation: 目的：提供使用羟丙基甲基纤维素制备含有左卡巴斯汀的纳米悬浮液的方法，以通过将固体分散剂再分散在水相中来增强药物的溶解度。 构成：使用羟丙基甲基菊糖制备含有左卡巴斯汀的纳米悬浮液的方法包括：将左卡巴斯坦和羟丙基甲基纤维素溶解在溶剂中并制备固体分散剂的步骤; 和分散固体分散剂的步骤。 左卡巴斯汀是盐酸左卡巴斯坦。 （标号）（AA）粒径（nm） （BB）实施例1; （CC）实施例2; （DD）实施例3; （EE）比较例1; （FF）比较例2; （GG）比较例3;
-
公开(公告)号：KR1020110104374A
公开(公告)日：2011-09-22
申请号：KR1020100023482
申请日：2010-03-16
Applicant: 성균관대학교산학협력단
IPC: A61K9/16 , A61K9/32 , A61K47/36 , A61K31/425
CPC classification number: A61K9/1652 , A61K9/1658 , A61K9/167 , A61K9/1682 , A61K31/428 , Y10S514/97
Abstract: 본 발명은 저장 안정성이 높은 프라미펙솔 디하이드로클로라이드(pramipexole dihydrochloride) 정제 및 이의 제조방법을 제공하기 위한 것이다.
-
公开(公告)号：KR102102461B1
公开(公告)日：2020-04-20
申请号：KR1020160031485
申请日：2016-03-16
Applicant: 주식회사 엘지화학 , 성균관대학교산학협력단
IPC: H01L51/42 , H01L31/0256
-
公开(公告)号：KR101560524B1
公开(公告)日：2015-10-15
申请号：KR1020150031157
申请日：2015-03-05
Applicant: 성균관대학교산학협력단
CPC classification number: B01D61/00 , B01D65/10 , B01D61/002
Abstract: 본발명은수처리기술분야에관한것으로, 보다상세하게는정삼투막처리장치에서의정삼투막베셀의막오염정도를실시간으로감지하기위한감시장치및 그방법을제공한다. 이를위하여, 본발명은정삼투막베셀을모사하여 FO 처리함으로써처리수와농축수로구분하는 FO 처리모사부를포함하며, 이는실제 FO 처리부의엘리먼트들을모사하는세 개의셀로이루어지고, 유입수저장부의수위에따라세 개의셀 중어느하나로유입수가유입된다.
Abstract translation: 本发明涉及一种水处理技术，更具体地涉及一种用于在正向渗透膜处理装置中实时监测正向渗透膜容器的膜污染水平的装配和方法。 本发明包括正向渗透（FO）处理模拟单元，其通过模拟正向渗透膜容器并执行FO处理将水区分为处理水和浓缩水，其中三个单元模拟FO处理单元中的元素，并且引发水 根据储水箱的水位进入三个电池之一。
-
-
-
-
-
-
-
-
-
Search Results
23
records
(took 0.037 seconds)
